...
【24h】

Commentary

机译:评论

获取原文
获取原文并翻译 | 示例
           

摘要

Anti-thrombotic therapy for people with chronic systolic heart failure remains controversial. Although it is recognised that people with heart failure are at increased risk of embolic and thrombotic events, no study has found a clear benefit of anti-thrombotic agents in heart failure. Furthermore, there are concerns that aspirin may have harmful effects in people with heart failure and that aspirin may attenuate, or even negate, the benefits of ACE inhibitors by blocking the production of vasodilator prostaglandins through inhibiting cyclooxygenase.The Warfarin/Aspirin Study of Heart Failure (WASH) assessed the feasibility of conducting a large trial with one arm receiving no anti-thrombotic therapy.
机译:慢性收缩性心力衰竭患者的抗血栓治疗仍存在争议。尽管已经认识到心力衰竭患者发生栓塞和血栓形成事件的风险增加,但尚无研究发现抗血栓形成剂对心力衰竭有明显益处。此外,有人担心阿司匹林可能对心力衰竭患者产生有害影响,并且阿司匹林可能通过抑制环加氧酶来阻止血管舒张药前列腺素的产生而削弱或什至削弱ACE抑制剂的益处。 (WASH)评估了一项大型试验,其中一只手臂未接受抗血栓治疗的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号